期刊文献+

老年慢性阻塞性肺疾病合并糖尿病患者免疫功能变化及临床意义 被引量:5

Changes and Significance of Immune Function in Old Patients with Chronic Obstructive Pulmonary Disease Complicated by Diabetes Mellitus
下载PDF
导出
摘要 【目的】研究老年慢性阻塞性肺疾病(COPD)合并糖尿病(DM)的患者免疫功能变化及临床意义。【方法165例年龄大于65岁的老年COPD稳定期患者分为COPD合并DM组(35例)和COPD组(30例),同时选择20例健康老年人作为对照组,分别测定外周血细胞免疫和体液免疫指标。【结果】COPD+DM组IgA、IgG、IgM、CD4+水平均低于COPD组和对照组,CD8+水平高于COPD组和对照组,CD4+/CD8+倒置更为明显,差异均有统计学意义(P〈0.05),而CD3+水平cOPD组和COPD+DM组之间无显著性差异(P〉0.05)。【结论】老年COPD合并DM的患者免疫功能低下,预防和控制DM对于提高COPD患者的免疫功能有重要意义。 [Objective] To explore the changes and significance of immune function in old patients with chronic obstructive pulmonary disease(COPD) complicated by diabetes mellitus (DM). [Methods] A total of 65 old patients (aged more than 65 years old) with stable COPD were divided into COPD with DM group( n =35) and COPD group( n = 30). Meanwhile, 20 healthy old people were chosen as the control group. Cellular immunity and humoral immunity indexes in peripheral blood were measured, [Results] IgA, IgG, IgM and CD4+ levels in COPD with DM group were lower than those in COPD group and control group, while CD8+ level was higher than that in COPE) group and control group, and the inversion of CD4+/CD8+ was more obvious, and there were significant differences( P 〈0.05). There was no significant difference in CD3+ between COPD group and COPD with DM group( P〉0.05). [Conclusion] Elderly patients with COPD complicated by DM have immune dysfunction. The prevention and control of DM is important for improving the immune function in patients with COPD.
出处 《医学临床研究》 CAS 2014年第10期1909-1911,共3页 Journal of Clinical Research
关键词 肺疾病 慢性阻塞性/并发症 糖尿病并发症 免疫球蛋白类 老年人 Pulmonary Disease, Chronic Obstructive/COs Diabetes Complications Immunoglobulins Aged
  • 相关文献

参考文献10

  • 1Celli BR, MacNee W. ATS /ERS Task Force. Standards for the diagnosis and treatment of patients with COPD: a summa ry of the ATS/ERS position paper[J]. Eur Respir J , 2004, 23(6) : 932-946.
  • 2Domagala-Kulawik J, Hoser G, Dabrowska M, et al . CD4+/ CD25+ cells in systemic inflammation in COPD[J]. Scand J Irnrnunol, 2011, 73( 1): 59-65.
  • 3Tzanakis N, Chrysofakis G, Tsoumakidou M, et al . Induced sputum CD8+ T-lymphocyte subpopulations in chronic ob- structive pulmonary disease [J].Respir Med , 2004,98 ( 1 ) 57-65.
  • 4慢性阻塞性肺疾病诊治指南(2007年修订版)[J].中华结核和呼吸杂志,2007,30(1):8-17. 被引量:8234
  • 52007年版中国2型糖尿病防治指南[J].中华内分泌代谢杂志,2008,24(2). 被引量:269
  • 6Turato G, Zuin R, Saetta M. Pathogenesis and pathology of COPD[J]. Respiration, 2001,68(2) : 117-128.
  • 7Baker EH,Janaway CH,Philips BJ, et al . Hyperglycaemia is associated with poor outcomes in patients admitted to hospital with acute exacerbations of chronic obstructive pulmonary disease[J]. Thorax, 2006,61(2) :284-289.
  • 8Tsoumakidou M,Tzanakis N,Kyriakou D, et al . Inflammato- ry cell profiles and T-lymphocyte subsets in chronic obstruc- tive pulmonary disease[J]. Clin Exp Allergy, 2004,34(2) : 234-240.
  • 9李蕾,马杉,薛元明.2型糖尿病患者的细胞免疫功能研究[J].中国误诊学杂志,2007,7(25):5962-5963. 被引量:16
  • 10Stevenson CR, Critchley JA, Forouhi NG, et al . Diabetes and the risk of tuberculosis: a neglected threat to public health[J]. Chronic Illn, 2007, 3(3): 228-245.

二级参考文献11

  • 1有创-无创序贯机械通气多中心研究协作组.以肺部感染控制窗为切换点行有创与无创序贯机械通气治疗慢性阻塞性肺疾病所致严重呼吸衰竭的随机对照研究[J].中华结核和呼吸杂志,2006,29(1):14-18. 被引量:279
  • 2GOLD Executive Committee[DB/OL].Guidelines:Global Strategy for Diagnosis,Management,and Prevention of COPD,November 2006[2006-11-18].http://www.goldcopd.com/Guidelineitem.asp? l1 =2-12 = 1&intId =989.
  • 3Celli BR,MacNee W,Committee members.Standard for the diagnosis and treatment of patients with COPD:a summary of the ATS/ERS position paper.Eur Respir J,2004,23:932-946.
  • 4Celli BR,Cote CG,Marin JM,ct al.The body mass index,airflow obstruction,dyspnea and exercise capacity index in chronic obstructive pulmonary disease.N Engl J Med,2004,350:1005-1012.
  • 5冉丕鑫 王辰 姚婉贞 等.我国部分地区慢性阻塞性肺疾病流行病学研究[J].中华结核和呼吸杂志,2007,.
  • 6Gupta D,Varma S,Khandelwal RL.Long-term effect of tumor necrosis factor-alpha treatment on insulin signaling pathway in HepG2 cells and HepG2 cells overexpressing constitutively active Akt/PKB[J].J Cell Biochem,2007,100(3):593-607.
  • 7Huth C,Heid IM,Vollmert C,et al.IL-6 gene promoter polymorphisms and type 2 diabetes:joint analysis of individual participants' data from 21 studies[J].Diabetes,2006,55(11):2915-2921.
  • 8Welsh N,Cnop M,Kharroubi I,et al.Is there a role for locally produced interleukin-1 in the deleterious effects of high glucose or the type 2 diabetes milieu to human pancreatic islets[J]?Diabetes,2005,54(12):3238-3244.
  • 9Leinonen E,Hurt-Camejo E,Wiklund O,et al.Insulin resistance and adiposity correlate with acute-phase reaction and soluble cell adhesion molecules in type 2 diabetes[J].Atherosclerosis,2003,166(2):387-394.
  • 10王辰,杜敏捷,曹大德,翁心植,吴小青,常青,王瑜.慢性肺原性心脏病急性发作期肺细小动脉血栓形成的病理观察[J].中华医学杂志,1997,77(2):123-125. 被引量:498

共引文献8514

同被引文献59

二级引证文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部